Medx Health (TSXV:MDX) Growth Rank : 0 (As of Dec. 13, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Medx Health Growth Rank?

Medx Health has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Medx Health Growth Rank Related Terms

Thank you for viewing the detailed overview of Medx Health's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Medx Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medx Health Corp (TSXV:MDX) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

MDXHF:USA

Address

1495 Bonhill Road, Unit 1, Mississauga, ON, CAN, L5T 1M2

Website

https://www.medxhealth.com

Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.

Executives

Edmund Ho	Director
Stephen Owen Lockyer	Director
David John Hennigar	Director
Luigi Canitano	Senior Officer
Gary Norman Van Nest	Director

Medx Health Headlines

No Headlines